Phase 4
Completed N=20
Stress Testing and Cardiac Magnetic Resonance
Coronary Disease
Source: ClinicalTrials.gov NCT00871260 ↗
Enrolled (actual)
20
Serious AEs
0.0%
Results posted
Jun 2021
Primary outcomePrimary: Major Adverse Cardiovascular Events — 0 Participants
◆ Published Evidence
Established
45citations · ~3 / year
Considerations when measuring myocardial perfusion reserve by cardiovascular magnetic resonance using regadenoson.
Summary
The purpose of this study is to better define the role of a comprehensive stress MRI (which includes myocardial perfusion imaging, optimized coronary imaging, and myocardial scar imaging) in medical practice and in patient health management. Information gathered from the healthy volunteers that participate in this study will be compared to information from the coronary artery disease patients in this study in order to help further our understanding.
Linked Publications
-
Considerations when measuring myocardial perfusion reserve by cardiovascular magnetic resonance using regadenoson.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Major Adverse Cardiovascular Events |
— | — |
| SECONDARY Relationship Between SPECT and CMR Results of Myocardial Perfusion Imaging |
— | — |
| SECONDARY Optimization of Coronary Imaging Using CMR |
— | — |
Eligibility Criteria
Inclusion Criteria
- Suspected coronary artery disease
- Symptoms of possible coronary artery disease
Exclusion Criteria
- Acute ST-elevation myocardial infarction
- Second or third degree AV block
- Severe Renal Disease (Glomerular Filtration Rate (GFR) <30cc/min or hemodialysis)
- Contra-indications to MRI (i.e. Implantable Cardioverter Defibrillator (ICD), pacemaker, aneurysm clip, etc)
- Hemodynamic instability
- Inability to provide informed consent
- Severe claustrophobia
- Pregnancy
- Age <18 years
Data sourced from ClinicalTrials.gov (NCT00871260) and the linked publication. Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.